BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17257070)

  • 1. Anti-GD3 monoclonal antibody effects on lymphocytes and antibody-dependent cellular cytotoxicity.
    Triozzi PL; Shah JJ; Wang WQ; Aldrich W; Edberg JC; Su K; Carlisle R; Conry R; LoBuglio AF; Forero A
    Cancer Biother Radiopharm; 2006 Dec; 21(6):553-60. PubMed ID: 17257070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
    Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.
    Chapman PB; Lonberg M; Houghton AN
    Cancer Res; 1990 Mar; 50(5):1503-9. PubMed ID: 2105840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibody.
    Chapman PB; Gillies SD; Houghton AN; Reilly RM
    Cancer Immunol Immunother; 1994 Sep; 39(3):198-204. PubMed ID: 7522964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
    Helfand SC; Dickerson EB; Munson KL; Padilla ML
    Cancer Res; 1999 Jul; 59(13):3119-27. PubMed ID: 10397254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
    Harel W; Shau H; Hadley CG; Morgan AC; Reisfeld RA; Cheresh DA; Mitchell MS
    Cancer Res; 1990 Oct; 50(19):6311-5. PubMed ID: 2400994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model.
    Helfand SC; Soergel SA; Donner RL; Gan J; Hank JA; Lindstrom MJ; Sondel PM
    J Immunother Emphasis Tumor Immunol; 1994 Oct; 16(3):188-97. PubMed ID: 7834118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma.
    Ramos AS; Parise CB; Travassos LR; Han SW; de Campos-Lima PO; de Moraes JZ
    Cancer Sci; 2011 Jan; 102(1):64-70. PubMed ID: 21070480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
    Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ
    MAbs; 2015; 7(3):494-504. PubMed ID: 25933349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha.
    Eisenthal A; Rosenberg SA
    J Immunol; 1989 Apr; 142(7):2307-13. PubMed ID: 2647849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
    Welt S; Carswell EA; Vogel CW; Oettgen HF; Old LJ
    Clin Immunol Immunopathol; 1987 Nov; 45(2):214-29. PubMed ID: 3665201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
    J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.
    Eisenthal A; Cameron RB; Rosenberg SA
    J Immunol; 1990 Jun; 144(11):4463-71. PubMed ID: 2111349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.
    de Palazzo IG; Gercel-Taylor C; Kitson J; Weiner LM
    Cancer Res; 1990 Nov; 50(22):7123-8. PubMed ID: 2146012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside.
    Nasi ML; Meyers M; Livingston PO; Houghton AN; Chapman PB
    Melanoma Res; 1997 Aug; 7 Suppl 2():S155-62. PubMed ID: 9578432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: detection of a target antigen for antibody-mediated cytolysis.
    Reaman GH; Taylor BJ; Merritt WD
    Cancer Res; 1990 Jan; 50(1):202-5. PubMed ID: 2403416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy.
    Boussiotis VA; Pardo NA; Collins H; Houghton A; Ritz J; Nadler LM; Soiffer RJ
    Eur J Immunol; 1996 Sep; 26(9):2149-54. PubMed ID: 8814260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
    Kawashima I; Tada N; Fujimori T; Tai T
    J Biochem; 1990 Jul; 108(1):109-15. PubMed ID: 2121721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.